Publications by authors named "Arzoo Ahmed"

Article Synopsis
  • - The paper investigates the ethical and legal challenges of obtaining consent for using genomic sequencing in newborn bloodspot screening programs, emphasizing the implications for children's health rights.
  • - It outlines the purpose of newborn screening, addresses the ethics involved, and critiques current consent practices in light of genomic advancements, presenting seven ongoing research projects on this topic.
  • - The authors propose the concept of the 'right of the asymptomatic at-risk child to be found' to advocate for "appropriate consent" in genomic applications, suggesting that it balances the benefits of universal screening with the complexities of new diagnostic technologies.
View Article and Find Full Text PDF

Genetic discrimination is an evolving phenomenon that impacts fundamental human rights such as dignity, justice and equity. Although, in the past, various definitions to better conceptualize genetic discrimination have been proposed, these have been unable to capture several key facets of the phenomenon. In this Perspective, we explore definitions of genetic discrimination across disciplines, consider criticisms of such definitions and show how other forms of discrimination and stigmatization can compound genetic discrimination in a way that affects individuals, groups and systems.

View Article and Find Full Text PDF

Newborn screening for treatable disorders is one of the great public health success stories of the twentieth century worldwide. This commentary examines the potential use of a new technology, next generation sequencing, in newborn screening through the lens of the Wilson and Jungner criteria. Each of the ten criteria are examined to show how they might be applied by programmes using genomic sequencing as a screening tool.

View Article and Find Full Text PDF

The transformative potential of whole genome sequencing (WGS) as a diagnostic tool in healthcare has been demonstrated by initiatives including the 100,000 Genomes Project and is now offered to certain patients in the National Health Service (NHS) in England. Building on these foundations, the utility of WGS in the newborn period can now be explored. Genomics England is working in partnership with NHS England and NHS Improvement and other healthcare, patient and public interest groups to design a research program embedded in the NHS to explore the potential challenges and implications of offering WGS in all newborns.

View Article and Find Full Text PDF